Allergy Therapeutics plc (AIM:AGY)

Allergy Therapeutics Statistics

Total Valuation

AIM:AGY has a market cap or net worth of GBP 664.92 million. The enterprise value is 681.58 million.

Market Cap	664.92M
Enterprise Value	681.58M

Important Dates

The next estimated earnings date is Monday, June 29, 2026.

Earnings Date	Jun 29, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM:AGY has 6.33 billion shares outstanding. The number of shares has increased by 4.81% in one year.

Current Share Class	6.33B
Shares Outstanding	6.33B
Shares Change (YoY)	+4.81%
Shares Change (QoQ)	+9.62%
Owned by Insiders (%)	0.14%
Owned by Institutions (%)	4.22%
Float	724.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.61
PB Ratio	156.49
P/TBV Ratio	13,569.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.15
EV / Sales	11.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-18.34

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 6.30.

Current Ratio	1.13
Quick Ratio	0.70
Debt / Equity	6.30
Debt / EBITDA	n/a
Debt / FCF	-0.72
Interest Coverage	-4.88

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-29.64%
Return on Invested Capital (ROIC)	-163.21%
Return on Capital Employed (ROCE)	-87.58%
Weighted Average Cost of Capital (WACC)	9.68%
Revenue Per Employee	98,106
Profits Per Employee	-82,491
Employee Count	584
Asset Turnover	0.80
Inventory Turnover	2.13

Taxes

In the past 12 months, AIM:AGY has paid 1.01 million in taxes.

Income Tax	1.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +87.37% in the last 52 weeks. The beta is 0.91, so AIM:AGY's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+87.37%
50-Day Moving Average	10.93
200-Day Moving Average	9.66
Relative Strength Index (RSI)	48.49
Average Volume (20 Days)	258,331

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:AGY had revenue of GBP 57.29 million and -48.18 million in losses. Loss per share was -0.01.

Revenue	57.29M
Gross Profit	29.92M
Operating Income	-34.14M
Pretax Income	-47.17M
Net Income	-48.18M
EBITDA	-31.61M
EBIT	-34.14M
Loss Per Share	-0.01

Balance Sheet

The company has 10.08 million in cash and 26.75 million in debt, with a net cash position of -16.67 million or -0.00 per share.

Cash & Cash Equivalents	10.08M
Total Debt	26.75M
Net Cash	-16.67M
Net Cash Per Share	-0.00
Equity (Book Value)	4.25M
Book Value Per Share	0.00
Working Capital	4.22M

Cash Flow

In the last 12 months, operating cash flow was -32.52 million and capital expenditures -4.64 million, giving a free cash flow of -37.16 million.

Operating Cash Flow	-32.52M
Capital Expenditures	-4.64M
Depreciation & Amortization	2.53M
Net Borrowing	26.71M
Free Cash Flow	-37.16M
FCF Per Share	-0.01

Margins

Gross margin is 52.22%, with operating and profit margins of -59.58% and -84.08%.

Gross Margin	52.22%
Operating Margin	-59.58%
Pretax Margin	-82.33%
Profit Margin	-84.08%
EBITDA Margin	-55.16%
EBIT Margin	-59.58%
FCF Margin	n/a

Dividends & Yields

AIM:AGY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.81%
Shareholder Yield	-4.81%
Earnings Yield	-7.25%
FCF Yield	-5.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:AGY has an Altman Z-Score of -2.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.17
Piotroski F-Score	2